MEREO BIOPHARMA GROUP PLC shareholders Q3 2023

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

MEREO BIOPHARMA GROUP PLC shareholders Q3 2023
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 17,285$22,2980.00%
RHUMBLINE ADVISERS 3,598$4,6380.00%
BNP PARIBAS FINANCIAL MARKETS 3$40.00%
TWO SIGMA INVESTMENTS, LP 142,602$183,9570.00%
US BANCORP \DE\ 13$170.00%
BANK OF AMERICA CORP /DE/ 9,218$11,8910.00%
WELLS FARGO & COMPANY/MN 230$2960.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
PRIMECAP MANAGEMENT CO/CA/ 79,000$101,9100.00%
GEODE CAPITAL MANAGEMENT, LLC 96,630$124,6520.00%
New England Capital Financial Advisors LLC 300$3870.00%
OPPENHEIMER & CO INC 14,000$18,0600.00%
HSBC HOLDINGS PLC 58,217$75,1000.00%
MORGAN STANLEY 6,693$8,6340.00%
Citadel Advisors 5,000$6,4500.00%
Plante Moran Financial Advisors, LLC 48$620.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 101,800$131,3220.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,800$17,8020.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 103,270$133,2180.00%
Highlander Capital Management, LLC 127$00.00%
External links

This page lists MEREO BIOPHARMA GROUP PLC's shareholders in Q3 2023. To view MEREO BIOPHARMA GROUP PLC's shareholder history, click here.